Form 4: Nuvalent's Chief Legal Officer, Deborah Ann Miller, Executes Stock Option and Sells Shares

Deborah Ann Miller, Chief Legal Officer of Nuvalent, Inc., exercised stock options and sold shares of Class A Common Stock on May 2, 2024, according to a recent SEC filing.

Summary

• On May 2, 2024, Deborah Ann Miller, the Chief Legal Officer of Nuvalent, Inc., executed a stock option to acquire 3,000 shares of Class A Common Stock at a price of $6.89 per share.
• Following the option exercise, Miller sold a total of 3,000 shares in multiple transactions at weighted average prices of $71.55, $72.58, and $73.13.
• These sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on December 27, 2023.
• After these transactions, Miller directly owns 33,300 shares of Class A Common Stock and 185,608 stock options.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reflects routine insider trading activity under a pre-arranged plan. There is no indication of positive or negative implications for the company's performance.

Industry Context

This filing is a routine disclosure of insider transactions and provides transparency to investors regarding the actions of company executives.

Comparison to Industry Standards

• Insider trading activity is common, and the transactions are being conducted under a pre-arranged 10b5-1 trading plan, which is a standard practice to avoid accusations of illegal insider trading.
• Comparable companies in the pharmaceutical industry also have similar insider trading disclosures.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding insider activity.
• The sales may have a minor impact on the stock price due to increased selling pressure, but this is likely to be minimal given the pre-planned nature of the transactions.

Key Dates